TELZIR Side Effects

7008414-0 | Dermatitis Bullous, Photodermatosis
on Sep 14, 2010 Female patient from RUSSIAN FEDERATION , weighting 123.5 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis bullous, photodermatosis. Telzir dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ). Patient was hospitalized.

6876266-5 | Foetal Growth Restriction
Patient was taking Telzir (View Usage). Patient had the following side effects: foetal growth restriction on Jul 21, 2010 from FRANCE Additional patient health information: Female patient , weighting 1.98 lb, . Telzir dosage: 700mg Twice Per Day. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), NORVIR (200mg Per Day) (View Norvir Review and Norvir Label ), KALETRA (View Kaletra Review and Kaletra Label ), BACTRIM (View Bactrim Review and Bactrim Label ), TRUVADA (View Truvada Review and Truvada Label ), ATRIPLA (View Atripla Review and Atripla Label ). Patient was hospitalized.

6876265-3 | Pre-eclampsia, Premature Baby
Adverse event was reported on Jul 21, 2010 by a Female patient taking Telzir (View Usage) (Dosage: 1400mgd Per Day) was diagnosed with hiv infection (What is hiv infection?), prophylaxis and. Location: FRANCE , weighting 163.1 lb, After Telzir was administered, patient had the following side effects: pre-eclampsia, premature baby. During the same period patient was treated with COMBIVIR (1tab Twice Per Day) (View Combivir Review and Combivir Label ), NORVIR (200mg Per Day) (View Norvir Review and Norvir Label ), KALETRA (4tab Per Day) (View Kaletra Review and Kaletra Label ), BACTRIM (View Bactrim Review and Bactrim Label ), TRUVADA (View Truvada Review and Truvada Label ), ATRIPLA (1tab Per Day) (View Atripla Review and Atripla Label ). Patient was hospitalized.

6867186-0 | Pre-eclampsia, Premature Baby
on Jul 16, 2010 Female patient from FRANCE , weighting 163.1 lb, was diagnosed with hiv infection (What is hiv infection?), prophylaxis and was treated with Telzir (View Usage). Patient experienced the following unwanted or unexpected effects: pre-eclampsia, premature baby. Telzir dosage: 1400mgd Per Day. During the same period patient was treated with COMBIVIR (1tab Twice Per Day) (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ), KALETRA (4tab Per Day) (View Kaletra Review and Kaletra Label ), BACTRIM (View Bactrim Review and Bactrim Label ), TRUVADA (View Truvada Review and Truvada Label ), ATRIPLA (1tab Per Day) (View Atripla Review and Atripla Label ). Patient was hospitalized.


6775059-7 | Foetal Growth Retardation
on Jun 11, 2010 Female patient from FRANCE , weighting 1.98 lb, was treated with Telzir (View Usage). Patient had the following side effects: foetal growth retardation. Telzir dosage: 700mg Twice Per Day. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ), KALETRA (View Kaletra Review and Kaletra Label ), BACTRIM (View Bactrim Review and Bactrim Label ), TRUVADA (View Truvada Review and Truvada Label ), ATRIPLA (View Atripla Review and Atripla Label ). Patient was hospitalized.

6775058-5 | Pre-eclampsia, Premature Baby
Patient was taking Telzir (View Usage). After Telzir was administered, patient had the following side effects: pre-eclampsia, premature baby on Jun 11, 2010 from FRANCE Additional patient health information: Female patient , weighting 163.1 lb, was diagnosed with hiv infection (What is hiv infection?), prophylaxis and. Telzir dosage: 1400mgd Per Day. During the same period patient was treated with COMBIVIR (1tab Twice Per Day) (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ), KALETRA (4tab Per Day) (View Kaletra Review and Kaletra Label ), BACTRIM (View Bactrim Review and Bactrim Label ), TRUVADA (View Truvada Review and Truvada Label ), ATRIPLA (1tab Per Day) (View Atripla Review and Atripla Label ). Patient was hospitalized.

6578288-0 | Foetal Growth Retardation
Adverse event was reported on Feb 05, 2010 by a Female patient taking Telzir (View Usage) (Dosage: 2tab Per Day) . Location: FRANCE , weighting 1.98 lb, Patient experienced the following unwanted or unexpected effects: foetal growth retardation. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ), KALETRA (View Kaletra Review and Kaletra Label ). Patient was hospitalized.

6503861-5 | Rhabdomyolysis
on Dec 09, 2009 Male patient from ITALY , 45 years of age, was diagnosed with thyroidectomy and was treated with Telzir (View Usage). Patient had the following side effects: rhabdomyolysis. Telzir dosage: . During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6432870-X | Acidosis, Hyperkalaemia
on Nov 02, 2009 Male patient from SPAIN , 43 years of age, was diagnosed with hiv infection (What is hiv infection?), liver transplant (What is liver transplant?) and was treated with Telzir (View Usage). After Telzir was administered, patient had the following side effects: acidosis, hyperkalaemia. Telzir dosage: 700mg Per Day. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), NORVIR (100mg Per Day) (View Norvir Review and Norvir Label ), TACROLIMUS (10mg Per Day) (View Tacrolimus Review and Tacrolimus Label ), SEGURIL (View Seguril Review and Seguril Label ), ALDACTONE (100mg Per Day) (View Aldactone Review and Aldactone Label ).

6133732-8 | Gastrointestinal Disorder
Patient was taking Telzir (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal disorder on Mar 20, 2009 from FRANCE Additional patient health information: Male patient , 39 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Telzir dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), NORVIR (View Norvir Review and Norvir Label ), REYATAZ (View Reyataz Review and Reyataz Label ).

6133730-4 | Mitochondrial Toxicity, Myositis
Adverse event was reported on Mar 20, 2009 by a Male patient taking Telzir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 58 years of age, Patient had the following side effects: mitochondrial toxicity, myositis (What is myositis?). During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), EPIVIR (View Epivir Review and Epivir Label ), COMBIVIR (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ), VIDEX (View Videx Review and Videx Label ), KALETRA (View Kaletra Review and Kaletra Label ).

6133728-6 | Haematotoxicity, Immune System Disorder, Lipodystrophy Acquired, Skin Disorder
on Mar 20, 2009 Male patient from FRANCE , 54 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). After Telzir was administered, patient had the following side effects: haematotoxicity, immune system disorder, lipodystrophy acquired, skin disorder. Telzir dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), RETROVIR (View Retrovir Review and Retrovir Label ), COMBIVIR (View Combivir Review and Combivir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), NORVIR (View Norvir Review and Norvir Label ), EMTRIVA (View Emtriva Review and Emtriva Label ), VIREAD (View Viread Review and Viread Label ), SUSTIVA (View Sustiva Review and Sustiva Label ).

6133726-2 | Adverse Event, Hepatotoxicity, Lipodystrophy Acquired
on Mar 20, 2009 Female patient from FRANCE , 37 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). Patient experienced the following unwanted or unexpected effects: adverse event, hepatotoxicity, lipodystrophy acquired. Telzir dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), NORVIR (View Norvir Review and Norvir Label ), VIREAD (View Viread Review and Viread Label ), REYATAZ (View Reyataz Review and Reyataz Label ), ZERIT (View Zerit Review and Zerit Label ).

6133725-0 | Gastrointestinal Disorder, Hyperbilirubinaemia
Patient was taking Telzir (View Usage). Patient had the following side effects: gastrointestinal disorder, hyperbilirubinaemia on Mar 20, 2009 from FRANCE Additional patient health information: Female patient , 44 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Telzir dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), NORVIR (View Norvir Review and Norvir Label ), ZERIT (View Zerit Review and Zerit Label ), KALETRA (View Kaletra Review and Kaletra Label ), REYATAZ (View Reyataz Review and Reyataz Label ).

6133724-9 | Hepatotoxicity
Adverse event was reported on Mar 20, 2009 by a Male patient taking Telzir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 55 years of age, After Telzir was administered, patient had the following side effects: hepatotoxicity. During the same period patient was treated with TRIZIVIR (View Trizivir Review and Trizivir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), NORVIR (View Norvir Review and Norvir Label ).

6133721-3 | Hepatotoxicity
on Mar 20, 2009 Male patient from FRANCE , 40 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). Patient experienced the following unwanted or unexpected effects: hepatotoxicity. Telzir dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ).

6133719-5 | Lipodystrophy Acquired, Mitochondrial Toxicity, Myositis
on Mar 20, 2009 Male patient from FRANCE , 35 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). Patient had the following side effects: lipodystrophy acquired, mitochondrial toxicity, myositis (What is myositis?). Telzir dosage: . During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), NORVIR (View Norvir Review and Norvir Label ), REYATAZ (View Reyataz Review and Reyataz Label ), VIDEX (View Videx Review and Videx Label ), VIREAD (View Viread Review and Viread Label ).

6133717-1 | Hepatotoxicity, Immune System Disorder
Patient was taking Telzir (View Usage). After Telzir was administered, patient had the following side effects: hepatotoxicity, immune system disorder on Mar 20, 2009 from FRANCE Additional patient health information: Male patient , 38 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Telzir dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), EMTRIVA (View Emtriva Review and Emtriva Label ), VIREAD (View Viread Review and Viread Label ).

6133716-X | Adverse Event, Mitochondrial Toxicity, Myositis
Adverse event was reported on Mar 20, 2009 by a Female patient taking Telzir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 40 years of age, Patient experienced the following unwanted or unexpected effects: adverse event, mitochondrial toxicity, myositis (What is myositis?). During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), NORVIR (View Norvir Review and Norvir Label ), VIDEX (View Videx Review and Videx Label ).

6133712-2 | Hepatotoxicity
on Mar 20, 2009 Male patient from FRANCE , 46 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). Patient had the following side effects: hepatotoxicity. Telzir dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), NORVIR (View Norvir Review and Norvir Label ), VIRACEPT (View Viracept Review and Viracept Label ), VIREAD (View Viread Review and Viread Label ).

6133711-0 | Haematotoxicity, Hepatotoxicity
on Mar 20, 2009 Male patient from FRANCE , 46 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). After Telzir was administered, patient had the following side effects: haematotoxicity, hepatotoxicity. Telzir dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), EPIVIR (View Epivir Review and Epivir Label ), NORVIR (View Norvir Review and Norvir Label ), VIRACEPT (View Viracept Review and Viracept Label ), VIREAD (View Viread Review and Viread Label ).

6133710-9 | Hepatotoxicity, Skin Disorder
Patient was taking Telzir (View Usage). Patient experienced the following unwanted or unexpected effects: hepatotoxicity, skin disorder on Mar 20, 2009 from FRANCE Additional patient health information: Female patient , 41 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Telzir dosage: . During the same period patient was treated with ZIAGEN (View Ziagen Review and Ziagen Label ), KIVEXA (View Kivexa Review and Kivexa Label ), NORVIR (View Norvir Review and Norvir Label ), VIDEX (View Videx Review and Videx Label ), INVIRASE (View Invirase Review and Invirase Label ).

6133707-9 | Hepatotoxicity
Adverse event was reported on Mar 20, 2009 by a Male patient taking Telzir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 42 years of age, Patient had the following side effects: hepatotoxicity. During the same period patient was treated with TRIZIVIR (View Trizivir Review and Trizivir Label ), NORVIR (View Norvir Review and Norvir Label ), VIRAMUNE (View Viramune Review and Viramune Label ), TIPRANAVIR (View Tipranavir Review and Tipranavir Label ), FUZEON (View Fuzeon Review and Fuzeon Label ).

6133702-X | Completed Suicide
on Mar 20, 2009 Female patient from FRANCE , 42 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). After Telzir was administered, patient had the following side effects: completed suicide. Telzir dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), NORVIR (View Norvir Review and Norvir Label ), VIREAD (View Viread Review and Viread Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

6133701-8 | Condition Aggravated, Hepatitis Viral
on Mar 20, 2009 Female patient from FRANCE , 47 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, hepatitis viral. Telzir dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), FUZEON (View Fuzeon Review and Fuzeon Label ), NORVIR (View Norvir Review and Norvir Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ).

6132190-7 | Gastrointestinal Disorder, Mitochondrial Toxicity, Myositis
Patient was taking Telzir (View Usage). Patient had the following side effects: gastrointestinal disorder, mitochondrial toxicity, myositis (What is myositis?) on Mar 20, 2009 from FRANCE Additional patient health information: Male patient , 37 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Telzir dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

6132189-0 | Hepatotoxicity
Adverse event was reported on Mar 20, 2009 by a Male patient taking Telzir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 36 years of age, After Telzir was administered, patient had the following side effects: hepatotoxicity. During the same period patient was treated with TRIZIVIR (View Trizivir Review and Trizivir Label ), EMTRIVA (View Emtriva Review and Emtriva Label ), VIREAD (View Viread Review and Viread Label ).

6132188-9 | Hepatotoxicity, Nervous System Disorder
on Mar 20, 2009 Female patient from FRANCE , 41 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). Patient experienced the following unwanted or unexpected effects: hepatotoxicity, nervous system disorder. Telzir dosage: . During the same period patient was treated with INVIRASE (View Invirase Review and Invirase Label ), NORVIR (View Norvir Review and Norvir Label ), KALETRA (View Kaletra Review and Kaletra Label ), TRUVADA (View Truvada Review and Truvada Label ).

6132186-5 |
on Mar 20, 2009 Male patient from FRANCE , 44 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). . Telzir dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), RETROVIR (View Retrovir Review and Retrovir Label ), ZIAGEN (View Ziagen Review and Ziagen Label ), TRIZIVIR (View Trizivir Review and Trizivir Label ), NORVIR (View Norvir Review and Norvir Label ).

6132184-1 |
Patient was taking Telzir (View Usage). on Mar 20, 2009 from FRANCE Additional patient health information: Male patient , 46 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Telzir dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), NORVIR (View Norvir Review and Norvir Label ), ZERIT (View Zerit Review and Zerit Label ).

6132183-X |
Adverse event was reported on Mar 20, 2009 by a Male patient taking Telzir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 39 years of age, . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ).

6132182-8 |
on Mar 20, 2009 Male patient from FRANCE , 64 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). . Telzir dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ).

6132181-6 |
on Mar 20, 2009 Male patient from FRANCE , 74 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). . Telzir dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), ZIAGEN (View Ziagen Review and Ziagen Label ), NORVIR (View Norvir Review and Norvir Label ), VIDEX (View Videx Review and Videx Label ).

6132180-4 | Completed Suicide
Patient was taking Telzir (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide on Mar 20, 2009 from FRANCE Additional patient health information: Male patient , 48 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Telzir dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ).

6129762-2 | Hiv Infection
Adverse event was reported on Mar 20, 2009 by a Male patient taking Telzir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 40 years of age, Patient had the following side effects: hiv infection (What is hiv infection?). During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), NORVIR (View Norvir Review and Norvir Label ), VIREAD (View Viread Review and Viread Label ).

6129761-0 |
on Mar 20, 2009 Male patient from FRANCE , 42 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). . Telzir dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), NORVIR (View Norvir Review and Norvir Label ), VIREAD (View Viread Review and Viread Label ).

6129759-2 | Hiv Infection
on Mar 20, 2009 Female patient from FRANCE , 42 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). Patient experienced the following unwanted or unexpected effects: hiv infection (What is hiv infection?). Telzir dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), FUZEON (View Fuzeon Review and Fuzeon Label ), TRUVADA (View Truvada Review and Truvada Label ).

6119549-9 | Rhabdomyolysis
Patient was taking Telzir (View Usage). Patient had the following side effects: rhabdomyolysis on Mar 04, 2009 from SPAIN Additional patient health information: Male patient , 44 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Telzir dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

6044080-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Enzyme Increased
Adverse event was reported on Jan 14, 2009 by a Female patient taking Telzir (View Usage) (Dosage: 700mg Twice Per Day) was diagnosed with hiv infection (What is hiv infection?) and. Location: ARGENTINA , 45 years of age, After Telzir was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic enzyme increased. During the same period patient was treated with 3TC (View 3tc Review and 3tc Label ).

6018026-3 | Abnormal Behaviour, Aggression, Alcohol Interaction, Anger, Blood Alcohol Increased, Confusional State, Memory Impairment, Road Traffic Accident
on Dec 18, 2008 Male patient from ITALY , 45 years of age, weighting 143.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, aggression, alcohol interaction, anger, blood alcohol increased, confusional state, memory impairment, road traffic accident. Telzir dosage: 1400mg Per Day. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), ART (View Art Review and Art Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6004069-2 | Hepatitis Cholestatic, Transaminases Increased
on Dec 11, 2008 Male patient from SPAIN , 40 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). Patient had the following side effects: hepatitis cholestatic, transaminases increased. Telzir dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), ZYPREXA (10mg Per Day) (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

5929535-7 | Treatment Failure, Underdose
Patient was taking Telzir (View Usage). After Telzir was administered, patient had the following side effects: treatment failure, underdose on Oct 15, 2008 from FRANCE Additional patient health information: Female patient , 59 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Telzir dosage: 700mg Twice Per Day. During the same period patient was treated with TMC125 (100mg Twice Per Day) (View Tmc125 Review and Tmc125 Label ), FUZEON (90mg Twice Per Day) (View Fuzeon Review and Fuzeon Label ), EMTRIVA (200mg Per Day) (View Emtriva Review and Emtriva Label ), RALTEGRAVIR (400mg Twice Per Day) (View Raltegravir Review and Raltegravir Label ).

5893326-6 | Overdose, Vomiting
Adverse event was reported on Sep 18, 2008 by a Male patient taking Telzir (View Usage) (Dosage: ) . Location: GERMANY , 35 years of age, Patient experienced the following unwanted or unexpected effects: overdose, vomiting. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), ALCOHOL (View Alcohol Review and Alcohol Label ). Patient was hospitalized.

5824447-1 | Blood Creatine Phosphokinase Increased, Blood Creatine Phosphokinase Mb Increased, Myoglobin Blood Increased, Rhabdomyolysis
on Jul 25, 2008 Female patient from FRANCE , 73 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, myoglobin blood increased, rhabdomyolysis. Telzir dosage: 700mg Twice Per Day. During the same period patient was treated with ELISOR (40mg Per Day) (View Elisor Review and Elisor Label ), NORVIR (100mg Twice Per Day) (View Norvir Review and Norvir Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), LASIX (80mg Per Day) (View Lasix Review and Lasix Label ), SUSTIVA (600mg Per Day) (View Sustiva Review and Sustiva Label ), 1 ALFA (.5mcg Per Day) (View 1 Alfa Review and 1 Alfa Label ), SODIUM BICARBONATE (1g Per Day) (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), STABLON (12.5mg Per Day) (View Stablon Review and Stablon Label ).

5787951-0 | Hepatotoxicity, Suicide Attempt
on Jun 20, 2008 Male patient from SPAIN , 40 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). After Telzir was administered, patient had the following side effects: hepatotoxicity, suicide attempt. Telzir dosage: 12g Per Day. During the same period patient was treated with NORVIR (2g Per Day) (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

5761179-2 | Anaemia, Leukopenia, Liver Function Test Abnormal, Neutropenia, Rash
Patient was taking Telzir (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, leukopenia, liver function test abnormal, neutropenia, rash (What is rash?) on May 29, 2008 from FRANCE Additional patient health information: Male patient , 47 years of age, was diagnosed with hiv infection (What is hiv infection?), epilepsy (What is epilepsy?) and. Telzir dosage: 700mg Twice Per Day. During the same period patient was treated with BACTRIM (1tab Per Day) (View Bactrim Review and Bactrim Label ), DEPAKENE (500mg Twice Per Day) (View Depakene Review and Depakene Label ), NORVIR (100mg Twice Per Day) (View Norvir Review and Norvir Label ), TRUVADA (1tab Per Day) (View Truvada Review and Truvada Label ), LEXOMIL (.5tab Per Day) (View Lexomil Review and Lexomil Label ), VITAMIN B1 (1tab Per Day) (View Vitamin B1 Review and Vitamin B1 Label ), VITAMIN B6 (1tab Per Day) (View Vitamin B6 Review and Vitamin B6 Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5719609-8 | Blood Creatinine Increased, C-reactive Protein Increased, Candiduria, Confusional State, Diarrhoea, Escherichia Sepsis, Inflammation, Leukocytosis, Nervous System Disorder
Adverse event was reported on Apr 18, 2008 by a Female patient taking Telzir (View Usage) (Dosage: 700mg Twice Per Day) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 65 years of age, Patient had the following side effects: blood creatinine increased, c-reactive protein increased, candiduria, confusional state, diarrhoea, escherichia sepsis, inflammation, leukocytosis, nervous system disorder. During the same period patient was treated with NORVIR (100mg Twice Per Day) (View Norvir Review and Norvir Label ), TRUVADA (1unit Per Day) (View Truvada Review and Truvada Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5709653-9 | Coagulopathy
on Apr 15, 2008 Female patient from FRANCE , 50 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Telzir (View Usage). After Telzir was administered, patient had the following side effects: coagulopathy. Telzir dosage: . During the same period patient was treated with SINTROM (View Sintrom Review and Sintrom Label ), VIRAMUNE (View Viramune Review and Viramune Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

5707057-6 | Anorexia, Blood Creatinine Increased, Haematuria, Headache, Leukocyturia, Nausea, Proteinuria, Pyrexia, Renal Failure
on Apr 08, 2008 Female patient from FRANCE , 48 years of age, was diagnosed with hiv infection (What is hiv infection?), prophylaxis, vaginal infection and was treated with Telzir (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, blood creatinine increased, haematuria, headache (What is headache?), leukocyturia, nausea (What is nausea?), proteinuria, pyrexia, renal failure. Telzir dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), NORVIR (View Norvir Review and Norvir Label ), BACTRIM (View Bactrim Review and Bactrim Label ), FLAGYL (View Flagyl Review and Flagyl Label ), VIBRAMYCIN (View Vibramycin Review and Vibramycin Label ). Patient was hospitalized.

5707037-0 | Abnormal Behaviour, Bulimia Nervosa, Cerebral Hygroma, Confusional State, Csf Glucose Decreased, Csf Protein Decreased, Delirium, Dyskinesia, Encephalitis
Patient was taking Telzir (View Usage). Patient had the following side effects: abnormal behaviour, bulimia nervosa, cerebral hygroma, confusional state, csf glucose decreased, csf protein decreased, delirium, dyskinesia, encephalitis (What is encephalitis?) on Apr 08, 2008 from FRANCE Additional patient health information: Male patient , 42 years of age, weighting 143.3 lb, was diagnosed with hiv infection (What is hiv infection?) and. Telzir dosage: 700mg Twice Per Day. During the same period patient was treated with TRUVADA (1tab Per Day) (View Truvada Review and Truvada Label ), VIREAD (View Viread Review and Viread Label ), EMTRIVA (View Emtriva Review and Emtriva Label ), NORVIR (View Norvir Review and Norvir Label ). Patient was hospitalized and became disabled.